It has been hypothesized that the RFX1 binding site is also present in the promoter of the human kinesin family member 3A gene, and that inhibition of this transcriptional process could be beneficial in suppressing invasive breast cancer [48]. The gene discussed is RFX1; the disease is invasive breast carcinoma.